915 related articles for article (PubMed ID: 26429879)
1. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.
Setti M; Osti D; Richichi C; Ortensi B; Del Bene M; Fornasari L; Beznoussenko G; Mironov A; Rappa G; Cuomo A; Faretta M; Bonaldi T; Lorico A; Pelicci G
Oncotarget; 2015 Oct; 6(31):31413-27. PubMed ID: 26429879
[TBL] [Abstract][Full Text] [Related]
2. Functional role of CLIC1 ion channel in glioblastoma-derived stem/progenitor cells.
Setti M; Savalli N; Osti D; Richichi C; Angelini M; Brescia P; Fornasari L; Carro MS; Mazzanti M; Pelicci G
J Natl Cancer Inst; 2013 Nov; 105(21):1644-55. PubMed ID: 24115360
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
4. Mutual Influence of ROS, pH, and CLIC1 Membrane Protein in the Regulation of G
Peretti M; Raciti FM; Carlini V; Verduci I; Sertic S; Barozzi S; Garré M; Pattarozzi A; Daga A; Barbieri F; Costa A; Florio T; Mazzanti M
Mol Cancer Ther; 2018 Nov; 17(11):2451-2461. PubMed ID: 30135216
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles in the biology of brain tumour stem cells--Implications for inter-cellular communication, therapy and biomarker development.
Nakano I; Garnier D; Minata M; Rak J
Semin Cell Dev Biol; 2015 Apr; 40():17-26. PubMed ID: 25721810
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells.
de Vrij J; Maas SL; Kwappenberg KM; Schnoor R; Kleijn A; Dekker L; Luider TM; de Witte LD; Litjens M; van Strien ME; Hol EM; Kroonen J; Robe PA; Lamfers ML; Schilham MW; Broekman ML
Int J Cancer; 2015 Oct; 137(7):1630-42. PubMed ID: 25802036
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
[No Abstract] [Full Text] [Related]
8. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA Signatures and Molecular Subtypes of Glioblastoma: The Role of Extracellular Transfer.
Godlewski J; Ferrer-Luna R; Rooj AK; Mineo M; Ricklefs F; Takeda YS; Nowicki MO; Salińska E; Nakano I; Lee H; Weissleder R; Beroukhim R; Chiocca EA; Bronisz A
Stem Cell Reports; 2017 Jun; 8(6):1497-1505. PubMed ID: 28528698
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways.
Hallal S; Mallawaaratchy DM; Wei H; Ebrahimkhani S; Stringer BW; Day BW; Boyd AW; Guillemin GJ; Buckland ME; Kaufman KL
Mol Neurobiol; 2019 Jun; 56(6):4566-4581. PubMed ID: 30353492
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide affects Extracellular Vesicles Released by Glioblastoma Cells.
André-Grégoire G; Bidère N; Gavard J
Biochimie; 2018 Dec; 155():11-15. PubMed ID: 29454008
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Vesicles from High-Grade Glioma Exchange Diverse Pro-oncogenic Signals That Maintain Intratumoral Heterogeneity.
Ricklefs F; Mineo M; Rooj AK; Nakano I; Charest A; Weissleder R; Breakefield XO; Chiocca EA; Godlewski J; Bronisz A
Cancer Res; 2016 May; 76(10):2876-81. PubMed ID: 27013191
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA and extracellular vesicles in glioblastoma: small but powerful.
Rooj AK; Mineo M; Godlewski J
Brain Tumor Pathol; 2016 Apr; 33(2):77-88. PubMed ID: 26968172
[TBL] [Abstract][Full Text] [Related]
14. Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives.
Barbieri F; Bosio AG; Pattarozzi A; Tonelli M; Bajetto A; Verduci I; Cianci F; Cannavale G; Palloni LMG; Francesconi V; Thellung S; Fiaschi P; Mazzetti S; Schenone S; Balboni B; Girotto S; Malatesta P; Daga A; Zona G; Mazzanti M; Florio T
J Exp Clin Cancer Res; 2022 Feb; 41(1):53. PubMed ID: 35135603
[TBL] [Abstract][Full Text] [Related]
15. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
[TBL] [Abstract][Full Text] [Related]
16. Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain.
van der Vos KE; Abels ER; Zhang X; Lai C; Carrizosa E; Oakley D; Prabhakar S; Mardini O; Crommentuijn MH; Skog J; Krichevsky AM; Stemmer-Rachamimov A; Mempel TR; El Khoury J; Hickman SE; Breakefield XO
Neuro Oncol; 2016 Jan; 18(1):58-69. PubMed ID: 26433199
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released from Glioblastoma Cells.
Choi D; Montermini L; Kim DK; Meehan B; Roth FP; Rak J
Mol Cell Proteomics; 2018 Oct; 17(10):1948-1964. PubMed ID: 30006486
[TBL] [Abstract][Full Text] [Related]
18. Exosomal L1CAM Stimulates Glioblastoma Cell Motility, Proliferation, and Invasiveness.
Pace KR; Dutt R; Galileo DS
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426278
[TBL] [Abstract][Full Text] [Related]
19. Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity.
Barbieri F; Verduci I; Carlini V; Zona G; Pagano A; Mazzanti M; Florio T
Front Oncol; 2019; 9():135. PubMed ID: 30918838
[TBL] [Abstract][Full Text] [Related]
20. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
